Author(s): Jurkat-Rott K, Holzherr B, Fauler M, Lehmann-Horn F
Five hereditary sodium channelopathies of skeletal muscle have been identified. Prominent symptoms are either myotonia or weakness caused by an increase or decrease of muscle fiber excitability. The voltage-gated sodium channel NaV1.4, initiator of the muscle action potential, is mutated in all five disorders. Pathogenetically, both loss and gain of function mutations have been described, the latter being the more frequent mechanism and involving not just the ion-conducting pore, but aberrant pores as well. The type of channel malfunction is decisive for therapy which consists either of exerting a direct effect on the sodium channel, i.e., by blocking the pore, or of restoring skeletal muscle membrane potential to reduce the fraction of inactivated channels.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/20237798
Author(s): George AL Jr
Author(s): Hudson AJ, Ebers GC, Bulman DE
Author(s): George AL Jr, Komisarof J, Kallen RG, Barchi RL
Author(s): West JW, Patton DE, Scheuer T, Wang Y, Goldin AL, et al.
Author(s): Popa MO, Alekov AK, Bail S, Lehmann-Horn F, Lerche H
Author(s): Chahine M, George AL Jr, Zhou M, Ji S, Sun W, et al.
Author(s): Yang N, Ji S, Zhou M, Ptácek LJ, Barchi RL, et al.
Author(s): Bouhours M, Luce S, Sternberg D, Willer JC, Fontaine B, et al.
Author(s): Kinoshita M, Sasaki R, Nagano T, Matsuda A, Nakamura S, et al.
Author(s): Jackson CE, Barohn RJ, Ptacek LJ
Author(s): Lehmann-Horn F, Jurkat-Rott K
Author(s): Wang GK, Russell C, Wang SY